These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 7684193)
1. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation. Haapasalo H; Isola J; Sallinen P; Kalimo H; Helin H; Rantala I Am J Pathol; 1993 May; 142(5):1347-51. PubMed ID: 7684193 [TBL] [Abstract][Full Text] [Related]
2. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas. Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478 [TBL] [Abstract][Full Text] [Related]
3. Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy. Grunnet ML; O'Neill A; Gilbert M; Hellman R Clin Neuropathol; 2000; 19(5):230-4. PubMed ID: 11048748 [TBL] [Abstract][Full Text] [Related]
4. Brain tumor: immunohistochemical studies on the stress-response proteins, p53 protein and proliferating cell nuclear antigen. Kato S; Morita T; Hori T; Kato M; Hirano A; Herz F; Ohama E Noshuyo Byori; 1995; 12(2):125-32. PubMed ID: 8867693 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization and correlation of p53 and PCNA expression in breast carcinoma. Goel MM; Goel R; Mehrotra A; Nath P; Agarwal PK; Singh K; Mehrotra R Indian J Exp Biol; 2000 Mar; 38(3):225-30. PubMed ID: 10927863 [TBL] [Abstract][Full Text] [Related]
6. J1-31 protein expression in astrocytes and astrocytomas. Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178 [TBL] [Abstract][Full Text] [Related]
7. A2B5 lineages of human astrocytic tumors and their recurrence. Xia CL; Du ZW; Liu ZY; Huang Q; Chan WY Int J Oncol; 2003 Aug; 23(2):353-61. PubMed ID: 12851684 [TBL] [Abstract][Full Text] [Related]
8. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype. Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600 [TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas. Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466 [TBL] [Abstract][Full Text] [Related]
10. Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome. Zolota V; Tsamandas AC; Aroukatos P; Panagiotopoulos V; Maraziotis T; Poulos C; Scopa CD Neuropathology; 2008 Feb; 28(1):35-42. PubMed ID: 18181833 [TBL] [Abstract][Full Text] [Related]
11. Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant. Klein MA; RĂ¼edi D; Nozaki M; Dell EW; Diserens AC; Seelentag W; Janzer RC; Aguzzi A; Hegi ME Oncogene; 2000 Nov; 19(47):5329-37. PubMed ID: 11103934 [TBL] [Abstract][Full Text] [Related]
12. Role of gemistocytes in astrocytoma progression. Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164 [TBL] [Abstract][Full Text] [Related]
13. Ethnicity delineates different genetic pathways in malignant glioma. Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811 [TBL] [Abstract][Full Text] [Related]
15. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2. Dabbs DJ Mod Pathol; 1995 Aug; 8(6):637-42. PubMed ID: 8532697 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival. Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536 [TBL] [Abstract][Full Text] [Related]
17. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Ebina M; Steinberg SM; Mulshine JL; Linnoila RI Cancer Res; 1994 May; 54(9):2496-503. PubMed ID: 7909277 [TBL] [Abstract][Full Text] [Related]